Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma
Background Lung adenocarcinoma (LUAD) is a highly heterogeneous disease, posing significant challenges to accurate prognosis prediction. Mitochondria play a central role in the energy metabolism of eukaryotic cells and can influence programmed cell death (PCD) mechanisms, which are critical in tumor...
Saved in:
| Main Authors: | Zhenfa Zhang, Lianmin Zhang, Yanan Cui, Guangyao Zhou, Pengpeng Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/10/e010008.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma
by: Peng Luo, et al.
Published: (2025-07-01) -
Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma
by: Ge Zhang, et al.
Published: (2025-02-01) -
Exploring ribosome biogenesis in lung adenocarcinoma to advance prognostic methods and immunotherapy strategies
by: Zipei Song, et al.
Published: (2025-05-01) -
Integrating Single‐Cell Transcriptomics and Machine Learning to Define an ac4C Gene Signature in Lung Adenocarcinoma
by: Yuan Wang, et al.
Published: (2025-08-01) -
In-depth exploration of programmed cell death-related subtypes and development of a prognostic signature model in lung adenocarcinoma
by: Desheng Zhou, et al.
Published: (2025-07-01)